Gujarat Kidney and Super Speciality Limited Ltd raises Rs 100 crore from anchor investors

Mumbai, December 19, 2025: Gujarat Kidney and Super Speciality, is a regional healthcare companies located in the central region of Gujarat and operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care, has garnered Rs 100 crore from anchor investors ahead of its initial public offering that opens for public subscription on December 22. The company informed the bourses that it allocated 87,73,120 equity shares at Rs 114 per share to anchor investors.

Some of the marquee institutions that participated in the anchor include Venus Investments VCC – Venus Stellar Fund, Khandelwal Finance Private Limited, Craft Emerging Market Fund PCC Citadel Capital Fund, Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund PCC – Arnesta Global Fund 1, Zeta Global Funds – Zeta Series C Fund PC, Innovative Vision Fund, Religo Commodities Ventures Trust and Sunrise Investment Trust.

Nirbhay Capital Services Private Limited is the book-running lead manager; and MUFG Intime India Limited is the registrar of the offer.

IPO Details

The IPO is a fresh issue of up to 2,20,00,000 equity shares. The issue size is Rs 250.8 crore at the upper end of the price band. 

The Initial Public Offering (“IPO” or “Issue”) of the Company will open on Monday, December 22, 2025, for subscription and close on Wednesday, December 24, 2025.

Investors can bid for a minimum of 128 Equity Shares and in multiples of 128 Equity Shares thereafter.

The Offer is being made through the book-building process, wherein not more than 75% of the net offer is allocated to qualified institutional buyers, and not more than 15% and 10% of the net offer is assigned to non-institutional bidders and retail individual bidders respectively. 

Company Information

The company is a regional healthcare companies located in the central region of Gujarat and operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. 

On a consolidated basis, the company operates seven (07) multispeciality hospitals and four (04) pharmacies operating within its hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), Ashwini Medical Store (Anand) and Apex Multispeciality & Trauma Center (Bharuch) with a total bed capacity of 490 beds, approved bed capacity of 445 beds and operational bed capacity of 340 beds.

The company categorizes its healthcare services as secondary services (which are surgical services) and tertiary Services (which are super speciality surgical services). Its hospitals are providing integrated diagnostic services, either in-house, and pharmacies that cater to its patients. The company has strategically focussed on the relatively under penetrated healthcare market in Gujarat where it has a presence in four cities, which it believes has provided it an understanding of regional nuances, patient culture and the mindset of medical professionals and where there is under-penetration of quality and affordable healthcare services.